SCOPUS 정보 검색 플랫폼

Eye

Volumn 18, Issue 5, 2004, Pages 466-469

A single transcutaneous injection with Botox® for dysthyroid lid retraction

(3) Shih, M J a Liao, S L b Lu, H Y a

a SHIN KONG WU HO SU MEMORIAL HOSPITAL (Taiwan)

b NATIONAL TAIWAN UNIVERSITY HOSPITAL (Taiwan)

Author keywords

Botulinum toxin type A; Thyroid eye disease; Upper lid retraction

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIPLOPIA; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; ECCHYMOSIS; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; EYE PAIN; EYELID; FEMALE; FOLLOW UP; HUMAN; MALE; PALPEBRAL FISSURE; PTOSIS; SINGLE DRUG DOSE; STRABISMUS SURGERY; SURGICAL TECHNIQUE; TRANSDERMAL DRUG ADMINISTRATION;

EID: 2942689373 PISSN: 0950222X EISSN: None Source Type: Journal
DOI: 10.1038/sj.eye.6700690 Document Type: Article

Times cited : (51)

References (14)

1
- 0029868358
- Clinical features of Graves' ophthalmopathy in an incidence cohort
- Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA et al. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996; 121: 284-290.
- (1996) Am. J. Ophthalmol. , vol.121 , pp. 284-290
- Bartley, G.B.¹ Fatourechi, V.² Kadrmas, E.F.³ Jacobsen, S.J.⁴ Ilstrup, D.M.⁵ Garrity, J.A.⁶

2
- 0028986662
- Results of Müllerotomy and levator aponeurosis transposition for the correction of upper eyelid retraction in Graves' disease
- Ceisler EJ, Bilyk JR, Rubin PA, Burks WR, Shore JW. Results of Müllerotomy and levator aponeurosis transposition for the correction of upper eyelid retraction in Graves' disease. Ophthalmology 1995; 102: 483-492.
- (1995) Ophthalmology , vol.102 , pp. 483-492
- Ceisler, E.J.¹ Bilyk, J.R.² Rubin, P.A.³ Burks, W.R.⁴ Shore, J.W.⁵

3
- 0034454231
- Management of Graves' ophthalmopathy: Reality and perspectives
- Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000; 21(2): 168-199.
- (2000) Endocr. Rev. , vol.21 , Issue.2 , pp. 168-199
- Bartalena, L.¹ Pinchera, A.² Marcocci, C.³

4
- 0014493097
- Treatment of dysthyroid ophthalmopathy with local guanethidine
- Cant JS, Lewis DR, Harrison MT. Treatment of dysthyroid ophthalmopathy with local guanethidine. Br J Ophthalmol 1969; 53: 233-238.
- (1969) Br. J. Ophthalmol. , vol.53 , pp. 233-238
- Cant, J.S.¹ Lewis, D.R.² Harrison, M.T.³

5
- 0026572858
- Octreotide and Graves' ophthalmopathy and pretibial myxoedema
- Chang TC, Kao SCS, Huang KM. Octreotide and Graves' ophthalmopathy and pretibial myxoedema. BMJ 1992; 304: 158.
- (1992) BMJ , vol.304 , pp. 158
- Chang, T.C.¹ Kao, S.C.S.² Huang, K.M.³

6
- 0029909390
- The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy
- Kung WC, Michon J, Tai KS, Chan FL. The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy. Thyroid 1996; 6(5): 381-384.
- (1996) Thyroid , vol.6 , Issue.5 , pp. 381-384
- Kung, W.C.¹ Michon, J.² Tai, K.S.³ Chan, F.L.⁴

7
- 0021592867
- Injection treatment of endocrine orbital myopathy
- Scott AB. Injection treatment of endocrine orbital myopathy. Doc Ophthalmol 1984; 58: 141-145.
- (1984) Doc. Ophthalmol. , vol.58 , pp. 141-145
- Scott, A.B.¹

8
- 0022197881
- Treatment of strabismus in adults with botulinum toxin A
- Elston JS, Lee JP, Hogg PC, Clark P. Treatment of strabismus in adults with botulinum toxin A. Br J Ophthalmol 1985; 69: 718-724.
- (1985) Br. J. Ophthalmol. , vol.69 , pp. 718-724
- Elston, J.S.¹ Lee, J.P.² Hogg, P.C.³ Clark, P.⁴

9
- 0023595123
- Botulinum toxin A induced protective ptosis
- Adams GG, Kirkness CM, Lee JP. Botulinum toxin A induced protective ptosis. Eye 1987; 1: 603-608.
- (1987) Eye , vol.1 , pp. 603-608
- Adams, G.G.¹ Kirkness, C.M.² Lee, J.P.³

10
- 0023914436
- Botulinum toxin A-induced protective ptosis in corneal disease
- Kirkness CM, Adams GG, Dilly PN, Lee JP. Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology 1988; 95: 473-480.
- (1988) Ophthalmology , vol.95 , pp. 473-480
- Kirkness, C.M.¹ Adams, G.G.² Dilly, P.N.³ Lee, J.P.⁴

11
- 0027753798
- Botulinum toxin type A in upper lid retraction of Graves' ophthalmopathy
- Ebner R. Botulinum toxin type A in upper lid retraction of Graves' ophthalmopathy, J Clin Neuro-ophthalmol 1993; 13: 258-261.
- (1993) J. Clin. Neuro-ophthalmol. , vol.13 , pp. 258-261
- Ebner, R.¹

12
- 0028226694
- Control of eyelid retraction associated with Graves' disease with botulinum A toxin
- Biglan AW. Control of eyelid retraction associated with Graves' disease with botulinum A toxin. Ophthalmic Surg 1994; 25: 186-188.
- (1994) Ophthalmic. Surg. , vol.25 , pp. 186-188
- Biglan, A.W.¹

13
- 0030791859
- Chemodenervation in treatment of upper eyelid retraction
- Ozkan SB, Can D, Soylev MF, Arsan AK, Duman S. Chemodenervation in treatment of upper eyelid retraction. Ophthalmologica 1997; 211: 387-390.
- (1997) Ophthalmologica , vol.211 , pp. 387-390
- Ozkan, S.B.¹ Can, D.² Soylev, M.F.³ Arsan, A.K.⁴ Duman, S.⁵

14
- 0036099862
- Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection
- Uddin JM, Davies PD. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology 2002; 109: 1183-1187.
- (2002) Ophthalmology , vol.109 , pp. 1183-1187
- Uddin, J.M.¹ Davies, P.D.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.